USPH News and Press, U.S. Physical Therapy Inc. From 09/01/22

U.S. Physical Therapy, Inc. ("USPH" or the “Company”) (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today announced an acquisition of a six-clinic physical therapy practice. The clinics are l...

Summary Investors have punished USPH on the back of its narrowed guidance and increased cost forecasts for FY22. Shares have sold off to 52-week lows despite no other material changes to long-term profitability trends. We believe the market consensus has overshot its call on U...

U.S. Physical Therapy, Inc. (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services (the "Company"), today announced that Chris Reading, Chief Executive Officer, will participate in the 2022 Midwest Ideas Conference ...

Stocks slipped on Wednesday following the release of anemic retail sales statistics, as investors took profits following a recent upswing. With the retreat, the Dow broke a five-session winning streak. Amid the overall decline, semiconductor stocks came under particular pressure. Analog...

U.S. Physical Therapy ( NYSE: USPH ) declares $0.41/share quarterly dividend , in line with previous. Forward yield 1.87% Payable Sept. 16; for shareholders of record Aug. 18; ex-div Aug. 17. See USPH Dividend Scorecard, Yield Chart, & Dividend Growth. Fo...

U.S. Physical Therapy, Inc. (USPH) Q2 2022 Earnings Conference Call August 4, 2022 10:30 ET Company Participants Chris Reading - President and Chief Executive Officer Carey Hendrickson - Chief Financial Officer Eric Williams - Co-Chief Operating Officer Graha...

Gainers: InVivo Therapeutics Holdings ( NVIV ) +164% . ChemoCentryx ( CCXI ) +109% . Minerva Neurosciences ( NERV ) +104% . Missfresh ( MF ) +66% . Society Pass ( SOPA ) +49% . Greenpro Capital ( GRNQ ) +48% . Yel...

U.S. Physical Therapy ( NYSE: USPH ), an operator of outpatient physical therapy clinics, dropped ~23% in the morning hours Thursday after the company missed forecasts for 2Q 2022 financials and revised the full-year guidance to reflect rising costs. Revenue for the ...

Gainers: InVivo Therapeutics ( NVIV ) +114% . ChemoCentryx CCXI +108% . GreenLight Biosciences ( GRNA ) +56% . Global Blood Therapeutics GBT +37% . NanoViricides ( NNVC ) +29% . Losers: Helius Medical Technologies ( HSDT...

U.S. Physical Therapy press release ( NYSE: USPH ): Q2 GAAP EPS of $0.87 misses by $0.12 . Revenue of $140.65M (+10.8% Y/Y) misses by $2.36M . For further details see: U.S. Physical Therapy GAAP EPS of $0.87 misses by $0.12, revenue of $140.65M misses by ...